Master Cell Banking
cGMP cell banking services establish well-characterized production cell banks supporting reliable biologics manufacturing and clinical drug substance supply
Explore Capabilities
Fill-Finish
Wheeler Bio’s partnership with Pyramid Pharma Services provides a seamless path to drug product fill-finish with integrated project oversight and flexible execution.
Contact Us
Partners for Excellence
Expertise Where It Counts
Through Wheeler Bio’s partnership with Pyramid Pharma Services, clients benefit from a seamless transition from drug substance manufacturing to fill-finish without the delays and complexity of traditional technology transfers. Wheeler Bio’s High-Touch project management approach remains consistent throughout the process, providing a single, accountable point of contact from development through final drug product manufacturing. Combined with flexible fill-finish scheduling, this integrated partnership helps reduce risk, maintain momentum, and keep programs on track despite evolving development and manufacturing needs.
cGMP Drug Product Fill-Finish with pyramid pharma services
Preferred Partnership Agreement
Clinical to commercial
Seamless transition of drug product to fill-finish for clinical to commercial scalesVial, Syringe, and Cartridge
On-site filling for products going into vials, syringes or cartridgesLiquid and Lyophilized
Liquid and lyophilized product can be accommodated across scales from clinical to commercialPackage and Assembly
Labeling packaging and device assembly all occurs under one roof and Wheeler Bio High-Touch management
Our Solutions
Precision at Every Scale
Starting with cell banks built to scale and moving to either non-cGMP production runs or full-scale cGMP manufacturing, Wheeler Bio’s deeply experienced team delivers precision at every stage.
Drug Substance Manufacturing
cGMP drug substance manufacturing services for clinical-stage biologics programs, supporting monoclonal antibodies and other antibody-based modalities
Explore Capabilities
Drug Product Manufacturing
Drug product from cGMP drug substance release through fill/finish coordination, drug product release testing, and ICH Q1A(R3)-aligned stability with the goal of providing a single point of coordination from drug substance release to clinical supply delivery
Learn More
A Partnership for Clinical Success
Have a program that needs both manufacturing and regulatory support? Wheeler’s partnership model means you get specialized expertise without losing the continuity of one project team